DENVER -- In patients with tuberculosis (TB), a novel fixed-dose combination of alpibectir-ethionamide had similar levels of bactericidal activity as isoniazid, with no serious adverse events and good ...

Discover comprehensive details about Ethionamide, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad hoc announcement pursuant to Art. 53 LR Basel, Switzerland. March 19, ...

Review the side-effects of Ethionamide as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Thyroid Function in the Patient over Time. Ethionamide was discontinued for other reasons, and her serum thyrotropin level decreased to 5.4 μU per milliliter. Ethionamide was restarted six months ...

Orphan designation is granted to drug candidates addressing life-threatening or chronically debilitating diseases affecting fewer than 5 in 10’000 EU residents EMA orphan status provides key ...

In cooperation with research partners in Germany and France, the infectious disease specialist Dr Jan Rybniker and his team at University Hospital Cologne and the University of Cologne’s Faculty of ...

March 25, 2005 — The U.S. Food and Drug Administration (FDA) and Wyeth Pharmaceuticals, Inc, have advised healthcare professionals via letter that the new film-coated formulation of ethionamide ...

In strains of tuberculosis that have developed drug resistance mutations, researchers have identified a secondary pathway that can be activated to reinstate drug sensitivity. In strains of ...

The early days of tuberculosis drug development produced several drugs that now are used only rarely. Many are poorly effective or associated with common or serious toxic effects. For example, because ...

Some of the most powerful tuberculosis antibiotics are prodrugs, compounds that need to be chemically modified by the disease-causing pathogen itself to become deadly. For those who study antibiotic ...

BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections caused by ...